HC Wainwright's 8 Healthcare Stock Picks

In a recent report, analysts at H.C. Wainwright outlined their 2015 outlook for healthcare stocks. Here's a breakdown of their top stocks to own in 2015.

  • Advaxis, Inc. ADXS: Analysts are hopeful that ADXS-CHER2 will gain approval by the U.S. Department of Agriculture for treatment of canine osteosarcoma in mid-2015, and the company's recent funds raise has put them in excellent position to initiate new clinical trials. Price target: $14.00 (+23.9 percent)
  • Aldeyra Therapeutics Inc ALDX: With two clinical programs on the company's top product (NS2) starting in 1Q15, analysts anticipate that data could be obtained in the second half of the year. Price target: $13.00 (+73.8 percent)
  • Alliqua Inc ALQA: Analysts believe that the company will move on to the expansion phase of its strategy in 2015 after the successful completion of the initial growth phase. Price target: $10.00 (+86.6 percent)
  • Edap Tms SA (ADR) EDAP: Analysts see growth from the HIFU franchise in Europe and strength in the lithotripsy business. Price target: $4.50 (+54.6 percent)
  • Genspera Inc GNSZ: Analysts expect positive data in 2015 from a Phase 2 study of G-202 for treatment of hepatocellular cancer. Price target: $2.00 (+185.7 percent)
  • Intelgenx Technologies Corp IGXT: Analysts project that Forvivo XL royalties could approach $7 million by 2025. Price target: $2.00 (+207.7 percent)
  • MELA Sciences Inc MELA: Analysts expect the launch of a new device in 2015 that could lead to increased adoption rates and higher margins. Price target: $4.50 (+198.0 percent)
  • Sorrento Therapeutics Inc SRNE: With the creation of three new major immunotherapy partnerships in 2014 and its two leading drug candidates (Cynviloq and RTX) on track for commercial profitability, analysts believe 2015 could be a pivotal year for the company. Price target: $13.00 (+29.4 percent)
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorLong IdeasHealth CarePrice TargetAnalyst RatingsTrading IdeasGeneralH.C. Wainwright
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!